We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $69.6B
1-Year Est. Return 42.52%
This Fund
S&P 500
This Quarter Est. Return
+1.34%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$42.2B
AUM Growth
-$1.23B
Cap. Flow
-$952M
Cap. Flow %
-2.26%
Top 10 Hldgs %
14.57%
Holding
2,171
New
150
Increased
772
Reduced
960
Closed
152

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$156M
2
PLD icon
Prologis
PLD
+$150M
3
CVX icon
Chevron
CVX
+$109M
4
QCOM icon
Qualcomm
QCOM
+$101M
5
PAYC icon
Paycom
PAYC
+$90.8M

Sector Composition

Rank Sector Weight
1 Technology 18.81%
2 Healthcare 17.11%
3 Financials 12.73%
4 Industrials 9.87%
5 Consumer Discretionary 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HURC icon
1076
Hurco Companies Inc
HURC
$149M
$1.11M ﹤0.01%
72,641
-12,216
-14% -$220K
TNC icon
1077
Tennant Co
TNC
$1.15B
$1.11M ﹤0.01%
11,248
RNR icon
1078
RenaissanceRe
RNR
$13.6B
$1.11M ﹤0.01%
4,947
-267
-5% -$59.8K
ORI icon
1079
Old Republic International
ORI
$9.82B
$1.1M ﹤0.01%
35,627
-2,825
-7% -$86.5K
UNM icon
1080
Unum
UNM
$15.1B
$1.1M ﹤0.01%
21,512
-8,363
-28% -$433K
HUBG icon
1081
HUB Group
HUBG
$2.02B
$1.1M ﹤0.01%
25,512
-15,121
-37% -$639K
EVER icon
1082
EverQuote
EVER
$824M
$1.1M ﹤0.01%
52,506
+51,961
+9,534% +$1.1M
SSP icon
1083
E.W. Scripps
SSP
$290M
$1.1M ﹤0.01%
348,788
-83,552
-19% -$265K
BJ icon
1084
BJs Wholesale Club
BJ
$11.8B
$1.09M ﹤0.01%
12,417
-356
-3% -$28.8K
RGLD icon
1085
Royal Gold
RGLD
$21.4B
$1.07M ﹤0.01%
8,588
-2,540
-23% -$317K
RDN icon
1086
Radian Group
RDN
$4.63B
$1.07M ﹤0.01%
34,535
CRNC icon
1087
Cerence
CRNC
$375M
$1.06M ﹤0.01%
375,722
+317,628
+547% +$2.26M
SBS icon
1088
Sabesp
SBS
$18.5B
$1.06M ﹤0.01%
406,303
PGC icon
1089
Peapack-Gladstone Financial
PGC
$804M
$1.06M ﹤0.01%
46,773
-181
-0.4% -$4.1K
DCI icon
1090
Donaldson
DCI
$9.98B
$1.06M ﹤0.01%
14,787
+1,729
+13% +$127K
PFGC icon
1091
Performance Food Group
PFGC
$14.4B
$1.06M ﹤0.01%
15,963
-843
-5% -$58.8K
NUVB icon
1092
Nuvation Bio
NUVB
$2.14B
$1.06M ﹤0.01%
361,406
+562
+0.2% +$1.72K
ECVT icon
1093
Ecovyst
ECVT
$1.16B
$1.05M ﹤0.01%
117,614
+23,889
+25% +$231K
DLR icon
1094
Digital Realty Trust
DLR
$67.9B
$1.05M ﹤0.01%
6,931
+2,307
+50% +$331K
SNPS icon
1095
Synopsys
SNPS
$73.1B
$1.05M ﹤0.01%
1,771
-904
-34% -$511K
LNW
1096
DELISTED
Light & Wonder
LNW
$1.05M ﹤0.01%
10,023
-1,752
-15% -$167K
NOC icon
1097
Northrop Grumman
NOC
$74.6B
$1.04M ﹤0.01%
2,387
+467
+24% +$213K
COHR icon
1098
Coherent
COHR
$57.9B
$1.04M ﹤0.01%
14,354
-719
-5% -$43.2K
MKSI icon
1099
MKS Inc
MKSI
$16.3B
$1.04M ﹤0.01%
7,953
-427
-5% -$53.9K
HON icon
1100
Honeywell
HON
$64.9B
$1.04M ﹤0.01%
5,151
-321
-6% -$61.1K

Similar funds

Federated Hermes's Q2 2024 Portfolio in Review

As of Q2 2024, Federated Hermes held 2,171 positions worth $42.2B, down 2.8% from $43.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Federated Hermes's Q2 2024 filing shows 150 new, 772 increased, 960 reduced and 152 closed positions. Its largest new stake was Loar Holdings: 729,296 shares worth $39M. The largest sale was Fusion Pharmaceuticals Inc. Common Shares, an estimated $230M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • Federated Hermes's largest Q2 2024 buy was Loar Holdings: 729,296 shares worth $39M.
  • Federated Hermes added most to Bristol-Myers Squibb in Q2 2024, an estimated $156M increase.
  • Federated Hermes's biggest Q2 2024 reduction was Kimberly-Clark, cutting an estimated $160M.
  • Federated Hermes fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $230M.
  • Federated Hermes's ten largest holdings make up 15% of its $42.2B portfolio in Q2 2024.
  • Federated Hermes opened 150 new positions and closed 152 in Q2 2024.
  • Federated Hermes's portfolio value fell 2.8% quarter-over-quarter to $42.2B.

Based on Federated Hermes's 13F filing for Q2 2024, filed 8 Aug 2024.